Leaven Launches First Shelf-Stable Instant Sourdough, Debuts as 2026 NEXTY Finalist
Leaven's shelf-stable Instant Sourdough comes in 0.25 oz sachets that make about six-to-eight loaves (SRP $8.99) and the company debuted at Natural Products Expo as a 2026 NEXTY finalist.

Leaven introduced a shelf-stable Instant Sourdough powder that the company says replaces a traditional starter while delivering "true sourdough fermentation, flavor, and performance," and made its Natural Products Expo debut as a 2026 NEXTY Award Finalist during events tied to February 16, 2026. The launch was announced in a press release datelined SAN DIEGO — February 16, 2025, which also promoted the NEXTY finalist status for 2026.
The product is described as a "shelf-stable powder of wild sourdough yeast and beneficial bacteria" and is sold in 0.25 ounce sachets and eight ounce professional/foodservice bags. Leaven's press materials state a 0.25 ounce sachet makes approximately six-to-eight loaves (SRP $8.99) while an eight ounce bag makes more than 100 loaves (SRP $65.99). Retail shelf sleeves with 20 sachets are available for in-store merchandising, per the company announcement.
Leaven lists its corporate facts alongside the product: headquartered in San Diego, founded in 2023 by two scientists, and led by CEO Cameron Martino. Investor messaging from Branch Venture Group frames the product as part of a mission to "elevate everyday baking and bring artisan-level sourdough into home kitchens, wholesale bakeries, restaurants, and more through a simpler, more convenient and consistent process."
Company and investor statements emphasize commercial and operational benefits. The press release and Branch Venture Group content call Instant Sourdough a "drop-in replacement for sourdough starters, eliminating the need for complex workflows" and claim it "reduces costs and food waste by making fermentation more reliable." Branch Venture Group further states "with over 100 paying customers and pilots underway with industry leaders, Leaven is proving product-market fit in both artisan and industrial markets," and highlights early rollouts with artisan bakeries, pizzerias, and industrial pilots.

Leaven and its investor materials attach scientific framing and study citations to performance claims: company and investor posts cite "Mold inhibition up to 21 days (PMID: 35159602)" and "Reduced staling and improved texture (PMID: 10898663 & 36832942)." Leaven’s LinkedIn copy states the powder uses wild lactic acid bacteria that "naturally produces organic acids, enzymes, and antifungals that help prevent mold and delay staling, without added preservatives." The company describes both Instant Sourdough and a related SKU, Instant Wild Yeast, as "all natural, gluten-free, non-GMO."
Noted gaps in the materials include no independent lab reports attached to the press release, no full ingredient or allergen lists, and no named retail or distribution partners. Branch Venture Group provides an investor contact email, info@branchventuregroup.com, and investor posts include social engagement markers (Likes: 131, Comments: 8) that accompany the fundraising and rollout messaging. Leaven’s launch materials present pricing, yields, scientific citations, and customer claims as company and investor statements; independent verification of mold-inhibition timelines, staling reduction, and the "over 100 paying customers" figure would require third-party testing or named case studies.
Know something we missed? Have a correction or additional information?
Submit a Tip

